Goals of ProsTIC's theranostics research in prostate cancer

Video

“We hope to further investigate next-generation PSMA-targeting molecules, develop new biomarkers to try to predict and monitor response to these novel therapies, optimize combinations with other treatments, and do some discovery research, including artificial intelligence [and] deep learning of our images,” says Michael S. Hofman, MBBS (Hons), FRACP, FAANMS, FICIS.

In this video, Michael S. Hofman, MBBS (Hons), FRACP, FAANMS, FICIS, discusses the goals and initiatives of the Prostate Cancer Theranostics and Imaging Center of Excellence (ProsTIC). Hofman is a nuclear medicine physician and director of ProsTIC, Melbourne, Australia.

Related Videos
Dr. Kyle A. Richards in an interview with Urology Times
3d rendered illustration - bladder cancer | Image Credit: © SciePro - stock.adobe.com
stethoscope on laptop keyboard
Randie White, MD, answers a question during a Zoom video interview
Udit Singhal, MD, answers a question during a Zoom video interview
Hospital hallway | Image Credit: © Paolese - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.